Clinical Pharmacists vs. Antimicrobial Resistance: Evidence-Based Strategies and Stewardship Impact in Modern Healthcare: A Review
Abstract
Background: Antimicrobial resistance (AMR) has been a significant problem to human health as antibiotics are misused and overused. Due to antimicrobial stewardship programs (ASPs), the emergence of antimicrobial resistance is hindering the performance of healthcare systems, and clinical pharmacists have become a necessity in these programs.
Objectives: This review discusses the changing role of clinical pharmacists in the fight against AMR through evidence-based methods.
Methods: Various strategies were reviewed including drug optimization, de-escalation, intravenous-to-oral conversions, therapeutic drug monitoring, and educating prescribers. The role of clinical pharmacists as part of multidisciplinary teams performing evidence-based interventions in real-time was emphasized.
Results: Intervention by pharmacists has been shown to significantly reduce inappropriate antibiotic use, hospital-acquired infections, resistance patterns, and healthcare expenditures, while improving patient outcomes and compliance with stewardship procedures. Additionally, their role in surveillance, audit-feedback systems, and policy development enhances the clinical effectiveness of ASPs in both hospital and community-based settings.
Conclusion: Challenges to the implementation of clinical pharmacist-led ASP initiatives such as limited resources, interprofessional barriers, and specialized training still exist. Nonetheless, the strategic integration of clinical pharmacist initiatives into ASPs is possibly the sustainable path forward to maintaining optimal antibiotic efficacy. This review emphasizes the importance of expanding pharmacist roles, promoting ongoing training, and promoting interprofessional collaboration to mitigate the global threat posed by AMR.
Keywords: Clinical pharmacists, Antimicrobial resistance (AMR), Antimicrobial stewardship (AMS), Evidence-based interventions, Drug optimization, Healthcare-associated infections
Keywords:
Clinical pharmacists, Antimicrobial resistance (AMR), Antimicrobial stewardship (AMS), Evidence-based interventions, Drug optimization, Healthcare-associated infectionsDOI
https://doi.org/10.22270/jddt.v15i8.7286References
1. Morrison L, Zembower TR. Antimicrobial resistance. Gastrointest Endosc Clin. 2020;30(4):619-635. https://doi.org/10.1016/j.giec.2020.06.004
2. Warrier A, Thanusubramanian H, Routray A, Mane A. Clinical and Economic Impact of Antimicrobial Resistance: Role of Antimicrobial Stewardship Programs in Indian Hospitals. J Acad Hosp Adm. 2023;35(2):60-70. https://doi.org/10.4103/jaha.jaha_7_24
3. Dighriri IM, Alnomci BA, Aljahdali MM, et al. The role of clinical pharmacists in Antimicrobial Stewardship Programs (ASPs): a systematic review. Cureus. 2023;15(12). https://doi.org/10.7759/cureus.50151
4. Tooke CL, Hinchliffe P, Bragginton EC, et al. β-Lactamases and β-Lactamase Inhibitors in the 21st Century. J Mol Biol. 2019;431(18):3472-3500. https://doi.org/10.1016/j.jmb.2019.04.002
5. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482. https://doi.org/10.3934/microbiol.2018.3.482
6. Ajulo S, Awosile B. Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS One. 2024;19(2):e0297921. https://doi.org/10.1371/journal.pone.0297921
7. Fekadu A, Woldeamanuel Y, Hailu A, Makonnen E. Global trends and projections in antimicrobial resistance. Lancet. 2025;405(10493):1905-1906. https://doi.org/10.1016/S0140-6736(25)00808-6
8. Naghavi M, Vollset SE, Ikuta KS, et al. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199-1226. https://doi.org/10.1016/S0140-6736(24)01867-1
9. Drew RH, White R, MacDougall C, et al. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy. 2009;29(5):593-607. https://doi.org/10.1592/phco.29.5.593
10. Zhou PY, Le Lim J, Wang Y, et al. P-1819. Point Prevalence Study Is A Useful Tool to Evaluate Effectiveness of Antimicrobial Stewardship Program Strategies in Surgical Departments at Singapore General Hospital. Open Forum Infect Dis. 2025;12(Suppl 1):ofae631-1982. https://doi.org/10.1093/ofid/ofae631.1982
11. Arena CJ, Veve MP, Fried ST, et al. Navigating performance measures for ambulatory antimicrobial stewardship: a review of HEDIS® and other metrics the steward should know. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e217. https://doi.org/10.1017/ash.2024.468
12. Bauerle W, O'Laughlin M, Evans H. Improving antibiotic stewardship in acute appendicitis through risk-based empiric treatment selection. Surg Infect. 2022;23(1):61-65. https://doi.org/10.1089/sur.2021.144
13. Xu J, Huang J, Yu Y, et al. The impact of a multifaceted pharmacist-led antimicrobial stewardship program on antibiotic use: evidence from a quasi-experimental study in the department of vascular and interventional radiology in a Chinese tertiary hospital. Front Pharmacol. 2022;13:832078. https://doi.org/10.3389/fphar.2022.832078
14. Lanckohr C, Boeing C, De Waele JJ, et al. Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A-TEAMICU survey. Ann Intensive Care. 2021;11(1):131. https://doi.org/10.1186/s13613-021-00917-2
15. Shrestha J, Zahra F, Cannady Jr P. Antimicrobial stewardship. StatPearls. 2023 Jun 20.
16. Jones KA, Onwubiko UN, Kubes J, et al. Reductions in inpatient fluoroquinolone use and postdischarge Clostridioides difficile infection (CDI) from a systemwide antimicrobial stewardship intervention. Antimicrob Steward Healthc Epidemiol. 2021;1(1):e32. https://doi.org/10.1017/ash.2021.197
17. Wang MS, Zimmerman G, Klein T, et al. Three stages of laboratory stewardship in improving appropriate Clostridioides difficile testing in a community-based setting. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e81. https://doi.org/10.1017/ash.2025.55
18. Petrović V, Jovanić G, Luković M. Effectiveness of prison work programs: Examples of certain programs in the USA. Specijalna edukacija i rehabilitacija. 2017;16(4):491-516. https://doi.org/10.5937/specedreh16-14182
19. Pringle J, Coley KC. Improving medication adherence: a framework for community pharmacy-based interventions. Integr Pharm Res Pract. 2015;Nov 16:175-183. https://doi.org/10.2147/IPRP.S93036
20. Das KS, Ranjan A, Sahu SS, et al. Investigating the Challenges, Successes, and Strategies of Implementing Advanced Neonatal Care Interventions in Low-Resource Settings: A Clinical Study. J Pharm Bioall Sci. 2024;16(Suppl 3):S2839-41. https://doi.org/10.4103/jpbs.jpbs_459_24
21. Dery RF, Perry E, Carson P, Skoy E. Implementation of antimicrobial stewardship certification program and its impact on low-resource settings. Am J Health Syst Pharm. 2025;Mar 24:zxaf077. https://doi.org/10.1093/ajhp/zxaf077
22. Gashegu M, Gahamanyi N, Ndayambaje FX, et al. Exploring Prescription Practices: Insights from an Antimicrobial Stewardship Program at a Tertiary Healthcare Facility, Rwanda. Antibiotics. 2024;13(6):548. https://doi.org/10.3390/antibiotics13060548
23. Nathwani D. BSAC Vanguard Series: The future of healthcare workers and antimicrobial stewardship-educate, innovate, or pay the price. J Antimicrob Chemother. 2022;77(5):1213-1215. https://doi.org/10.1093/jac/dkab484
24. Abbas S. The challenges of implementing infection prevention and antimicrobial stewardship programs in resource-constrained settings. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e45. https://doi.org/10.1017/ash.2024.35
25. Fishman N. Antimicrobial stewardship. Am J Infect Control. 2006;34(5):S55-S63. https://doi.org/10.1016/j.ajic.2006.05.237
26. Moro ML, Gagliotti C. Antimicrobial resistance and stewardship in long-term care settings. Future Microbiol. 2013;8(8):1011-1025. https://doi.org/10.2217/fmb.13.75
27. Ruiz-Ramos J, Frasquet J, Roma E, et al. Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units. J Med Econ. 2017;20(6):652-659. https://doi.org/10.1080/13696998.2017.1311903
Published
Abstract Display: 509 
PDF Downloads: 436 PDF Downloads: 121 How to Cite
Issue
Section
Copyright (c) 2025 Nigel Viju Thomas , Souman Samanta , Muchukota Sushma , Madhuvan H.S., Shobha Rani R.H.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.